People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...

When you’re committed to losing weight, it can be overwhelming to know where to begin. Whether you need guidance on your food choices, workouts, or overall lifestyle, there certainly isn’t a ...

Empower your fitness and health journey using a mobile app. Check out a brief review of some of the most popular names (Lasta App, BetterMe, and Noom) ...

In this episode, MM+M Pharma Editor Lecia Bushak sits down with Noom’s CEO Geoff Cook and Chief Medical Officer Dr. Jeffrey Egler to discuss the launch of their new Microdose GLP-1 program, designed ...

Highmark is partnering with Noom to offer free, AI-powered weight management programs to eligible members, focusing on ...

SAN FRANCISCO--(BUSINESS WIRE)--Collective Health, a leader in employee health benefits, and digital healthcare leader Noom’s enterprise division, Noom Health, have partnered to deliver Collective ...

People with prediabetes using health coaching app Noom achieved levels of success that are comparable to traditional diabetes prevention programs for weight loss and health management, a new study ...

If you put on a few extra pounds during the COVID-19 pandemic and now you're trying to get moving and lose the weight, the Better Business Bureau has a warning about one health and fitness web-based ...

Wellness app maker Noom has secured an additional $2.9 million, bringing their latest round to $7 million. The round was led by New York-based RRE Ventures with participation from TransLink Capital, ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...